Here’s whether Merck & Co., Inc. (MRK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+1.61% over 10 days); RSI 49 — healthy momentum range; strong 1-year return of +55.7%; 3-month momentum positive (+9.4%). Concerns: below the 50-day MA (medium-term momentum negative). Currently 4.8% off its 52-week high. Score: +5/7.
MRK is holding above its long-term 200-day MA ($98.41) but has slipped below the 50-day MA ($119.13), pointing to short-term weakness in an otherwise intact trend. An RSI of 48.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +55.7% compares to +35.1% for SPY (beat the market by 20.6%).
$10,000 invested 1 year ago→ $15,573 today
vs. S&P 500 (SPY) — same period beat market by 20.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($98.41)
✗Above 50-day MA ($119.13)
✓RSI(14) neutral zone (30–70) — currently 48.7
✓Positive return (+55.7%)
✓Within 10% of period high (−4.8%)
Period Range $119.07
$73.31$125.14
RSI (14) 48.7
0 · OversoldOverbought · 100
Key Metrics
Price$119.07
Period Return+55.7%
Period High$125.14
Period Low$73.31
Drawdown−4.8%
MA-50$119.13
MA-200$98.41
RSI (14)48.7
Avg Volume (30d)9.8M
vs. SPYbeat by 20.6%
Return Rank#350 of 996
Trend Signals
Price is above the 200-day moving average ($98.41)
Price is below the 50-day moving average ($119.13)